SCHEMBL314030

SCHEMBL314030

C=Cc1cccc(S(=O)(=O)OCC)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.42
TP53 P04637 1/20 0.42
MCL1 Q07820 2/20 0.41
PTPN1 P18031 6/20 0.35
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
PTGS2 P35354 1/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HDAC8 Q9BY41 1/20 0.33
PSIP1 O75475 1/20 0.32
DRD2 P14416 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9260797 0.82 ALDH1A1 (0.44) TDP1TP53PTPN1PRMT5WDR77
SCHEMBL313512 0.81 TDP1 (0.46) TDP1TP53MCL1PTGS2ALDH1A1
SCHEMBL313392 0.80 TDP1 (0.50) TDP1MCL1PTPN1ALDH1A1SMN1; SMN2
SCHEMBL28933558 0.78 TDP1 (0.48) TDP1MCL1PTPN1ALDH1A1SMN1; SMN2
SCHEMBL3279948 0.76 KMT2A (0.51) ALDH1A1MEN1KMT2A
SCHEMBL11529174 0.76 LMNA (0.57) TDP1TP53ALDH1A1TSHRSMN1; SMN2
SCHEMBL11330739 0.75 TDP1 (0.50) TDP1TP53MCL1PTGS2ALDH1A1
SCHEMBL6254180 0.75 LMNA (0.48) TDP1TP53MCL1ALDH1A1TSHR
SCHEMBL4243805 0.75 ATM (0.42) ALDH1A1DRD2MEN1KMT2A
SCHEMBL8398078 0.75 LOXL2 (0.43) TDP1PTPN1ALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025127086-A1 ALLERGEN-REDUCING PARTICLES, ALLERGEN-REDUCING COATING MATERIAL, AND ALLERGEN-REDUCING PRODUCT 積水化学工業株式会社 2025-06-19 WO disclosed
CN-117042606-B Virus infection suppressing particles and virus infection suppressing product 积水化学工业株式会社 2025-02-18 CN disclosed
CN-117042606-A Virus infection suppressing particles and virus infection suppressing product 积水化学工业株式会社 2023-11-10 CN disclosed
CN-104880908-B Photosensitive resin composition 住友化学株式会社 2019-12-13 CN disclosed
US-20150164070-A1 INFLUENZA VIRUS INFECTION INHIBITOR FOR FIBER PROCESSING, FIBER PRODUCT USING THE SAME, AND METHOD FOR PRODUCING THE SAME SEKISUI CHEMICAL CO., LTD. (JP) 2015-06-18 US disclosed
US-8679240-B2 Allergen inhibitor, allergen-inhibiting product, allergen inhibiting method, and use as allergen inhibitor SEKISUI CHEMICAL CO., LTD. (JP) 2014-03-25 US disclosed
US-20130236528-A1 ALLERGEN INHIBITOR, ALLERGEN-INHIBITING PRODUCT, ALLERGEN INHIBITING METHOD, AND USE AS ALLERGEN INHIBITOR SEKISUI CHEMICAL CO., LTD. (JP) 2013-09-12 US disclosed
US-8454735-B2 Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor SEKISUI CHEMICAL CO., LTD. (JP) 2013-06-04 US disclosed
US-8444961-B2 RNA virus infection inhibitor, method for inhibition of infection by RNA virus, RNA virus infection-inhibiting product, and use as RNA virus infection inhibitor SEKISUI CHEMICAL CO., LTD. (JP) 2013-05-21 US disclosed
EP-2444095-A1 RNA VIRUS INFECTION INHIBITOR, METHOD FOR INHIBITION OF INFECTION BY RNA VIRUS, PRODUCTS FOR INHIBITION OF INFECTION BY RNA VIRUS, AND USE AS RNA VIRUS INFECTION INHIBITOR Sekisui Chemical Co., Ltd. (JP) 2012-04-25 EP disclosed
US-20120093763-A1 RNA VIRUS INFECTION INHIBITOR, METHOD FOR INHIBITION OF INFECTION BY RNA VIRUS, RNA VIRUS INFECTION-INHIBITING PRODUCT, AND USE AS RNA VIRUS INFECTION INHIBITOR SEKISUI CHEMICAL CO., LTD. (JP) 2012-04-19 US disclosed
US-8093342-B2 Polymer, charge control agent, and toner for developing electrostatic latent images CANON KABUSHIKI KAISHA (JP) 2012-01-10 US disclosed
US-20110154791-A1 ALLERGEN INHIBITOR, ALLERGEN-INHIBITING PRODUCT, ALLERGEN INHIBITION METHOD, AND USE AS ALLERGEN INHIBITOR SEKISUI CHEMICAL CO., LTD. 2011-06-30 US disclosed
US-20100291482-A1 NOVEL POLYMER, CHARGE CONTROL AGENT, AND TONER FOR DEVELOPING ELECTROSTATIC LATENT IMAGES CANON KABUSHIKI KAISHA (JP) 2010-11-18 US disclosed
EP-2243809-A1 ALLERGEN INHIBITOR, ALLERGEN-INHIBITING PRODUCT, ALLERGEN INHIBITION METHOD, AND USE AS ALLERGEN INHIBITOR Sekisui Chemical Co., Ltd. (JP) 2010-10-27 EP disclosed
US-20070117945-A1 NOVEL POLYMER, CHARGE CONTROL AGENT, AND TONER FOR DEVELOPING ELECTROSTATIC LATENT IMAGES CANON KABUSHIKI KAISHA (JP) 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164070-A1 INFLUENZA VIRUS INFECTION INHIBITOR FOR FIBER PROCESSING, FIBER PRODUCT USING THE SAME, AND METHOD FOR PRODUCING THE SAME TFPI, TFPI2, MYO1G TDP1 3671/4885TP53 4149/4885MCL1 3482/4885
US-20120093763-A1 RNA VIRUS INFECTION INHIBITOR, METHOD FOR INHIBITION OF INFECTION BY RNA VIRUS, RNA VIRUS INFECTION-INHIBITING PRODUCT, AND USE AS RNA VIRUS INFECTION INHIBITOR NSUN3, RNASEH1, RNASEL TDP1 2770/4885TP53 2495/4885MCL1 3161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.